LeafNLP Demos
Back to explore

Report #2891133

Received Mar 30, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
53 yrs
State
OH
Recovered
Recovered
Vaccinated
Mar 4, 2026
Onset
Mar 4, 2026
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS193N4JIM / LA

Symptoms (1)

Injection site pain

Symptom narrative

Site: Pain at Injection Site-Mild, Systemic: no reaction-Mild, Additional Details: the Shingrix vaccine was inadvertently documented as a prefilled syringe formulation (GSK Shingrix 0.5ml Recombinant IM; Without Preservative). A reconstituted formulation (GSK Shingrix 0.5ml Recombinant IM; Without Preservative) was actually administered.